ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628561 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628561; 2) Community: the network communities that were significantly associated with the response to NSC 628561; 3) Molecule: the relationships between components within communities and NSC 628561; 4) MDR: the compounds that were significantly associated with the NSC 628561.

NSC Compound Enrichment Correlation
NSC 688074 16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone 0.0235234559682127 0.53183114
NSC 135037 Jatrophone 0.023523455968213 0.53790678
NSC 146769 Null 0.0284045326811616 0.10550587
NSC 174218 Phenol, 2,2'-[1,2-ethanediylbis(nitrilomethylidyne)]bis-, compd. with dichlorodipropylstannane (1:1) 0.0284045326811616 0.62727805
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0284045326811616 0.29667143
NSC 24500 2,6-Dimethoxy-p-benzoquinone 0.0284045326811616 0.40064279
NSC 33419 1,3-Diamino-5-methylphenazinium chloride 0.0284045326811616 0.26861603
NSC 341936 Adenosine, 2-bromo-2'-deoxy- 0.0284045326811616 0.25289122
NSC 606985 Camptothecin Derivative 0.0284045326811616 -0.049951352
NSC 618939 Camptothecin Derivative 0.0284045326811616 0.035494354
Total:91  Current:53    [First] [Prev] [Next] [Last]